These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12417354)

  • 1. The costs of vascular dementia: a comparison with Alzheimer's disease.
    Fillit H; Hill J
    J Neurol Sci; 2002 Nov; 203-204():35-9. PubMed ID: 12417354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of healthcare utilization and costs for vascular dementia in a community-dwelling population.
    Hill J; Fillit H; Shah SN; del Valle MC; Futterman R
    J Alzheimers Dis; 2005 Sep; 8(1):43-50. PubMed ID: 16155348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excess Costs Associated with Possible Misdiagnosis of Alzheimer's Disease Among Patients with Vascular Dementia in a UK CPRD Population.
    Happich M; Kirson NY; Desai U; King S; Birnbaum HG; Reed C; Belger M; Lenox-Smith A; Price D
    J Alzheimers Dis; 2016 May; 53(1):171-83. PubMed ID: 27163798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and economic characteristics associated with direct costs of Alzheimer's, frontotemporal and vascular dementia in Argentina.
    Rojas G; Bartoloni L; Dillon C; Serrano CM; Iturry M; Allegri RF
    Int Psychogeriatr; 2011 May; 23(4):554-61. PubMed ID: 21044400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare.
    Hill JW; Futterman R; Duttagupta S; Mastey V; Lloyd JR; Fillit H
    Neurology; 2002 Jan; 58(1):62-70. PubMed ID: 11781407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy.
    Fillit H; Hill JW; Futterman R
    Fam Med; 2002; 34(7):528-35. PubMed ID: 12144008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of Alzheimer's disease and related dementia in managed-medicare.
    Gutterman EM; Markowitz JS; Lewis B; Fillit H
    J Am Geriatr Soc; 1999 Sep; 47(9):1065-71. PubMed ID: 10484247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health service utilization among Alzheimer's disease patients: evidence from managed care.
    Frytak JR; Henk HJ; Zhao Y; Bowman L; Flynn JA; Nelson M
    Alzheimers Dement; 2008 Sep; 4(5):361-7. PubMed ID: 18790463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
    Lu S; Hill J; Fillit H
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular cognitive impairment and dementia expenditures: 7-year inpatient cost description in community dwellers.
    Ramos-Estebanez C; Moral-Arce I; Rojo F; Gonzalez-Macias J; Hernandez JL
    Postgrad Med; 2012 Sep; 124(5):91-100. PubMed ID: 23095429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost of Alzheimer's disease in managed care: a cross-sectional study.
    Leon J; Neumann PJ
    Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The costs of caring: medical costs of Alzheimer's disease and the managed care environment.
    Murman DL
    J Geriatr Psychiatry Neurol; 2001; 14(4):168-78. PubMed ID: 11794445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, resource utilization and costs of vascular dementia compared to Alzheimer's dementia in a population setting.
    Sicras A; Rejas J; Arco S; Flores E; Ortega G; Esparcia A; Suárez A; Gordillo MJ
    Dement Geriatr Cogn Disord; 2005; 19(5-6):305-15. PubMed ID: 15785031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer's Disease Versus Vascular Dementia.
    D'Onofrio G; Panza F; Sancarlo D; Addante F; Solfrizzi V; Cantarini C; Mangiacotti A; Lauriola M; Cascavilla L; Paris F; Lozupone M; Daniele A; Greco A; Seripa D
    J Alzheimers Dis; 2018; 62(2):699-711. PubMed ID: 29480171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.
    Rice DP; Fillit HM; Max W; Knopman DS; Lloyd JR; Duttagupta S
    Am J Manag Care; 2001 Aug; 7(8):809-18. PubMed ID: 11519239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of eating behavior in elderly patients with Alzheimer's disease and vascular dementia: a first report. - Comparison of disturbed eating behavior - ].
    Edahiro A; Hirano H; Yamada R; Chiba Y; Watanabe Y
    Nihon Ronen Igakkai Zasshi; 2013; 50(5):651-60. PubMed ID: 24622139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of donepezil therapy on health costs in a Medicare managed care plan.
    Hill JW; Futterman R; Mastey V; Fillit H
    Manag Care Interface; 2002 Mar; 15(3):63-70. PubMed ID: 11925682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of the family cost of private nursing home care versus home care for patients with dementia in Taiwan.
    Chiu L; Shyu WC
    Chang Gung Med J; 2001 Oct; 24(10):608-14. PubMed ID: 11771182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia.
    Fuh JL; Wang SJ; Cummings JL
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1337-41. PubMed ID: 16170072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical costs of Alzheimer's disease misdiagnosis among US Medicare beneficiaries.
    Hunter CA; Kirson NY; Desai U; Cummings AK; Faries DE; Birnbaum HG
    Alzheimers Dement; 2015 Aug; 11(8):887-95. PubMed ID: 26206626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.